| Target and Pathway |
Top |
| Target(s) |
Janus kinase 1 (JAK-1) |
Target Info
|
Inhibitor |
[1] |
| Janus kinase 3 (JAK-3) |
Target Info
|
Inhibitor |
[1] |
| TYK2 tyrosine kinase (TYK2) |
Target Info
|
Inhibitor |
[1] |
| Target's Patent Info |
Janus kinase 1 (JAK-1) |
Target's Patent Info
|
[1] |
| Janus kinase 3 (JAK-3) |
Target's Patent Info
|
[1] |
| TYK2 tyrosine kinase (TYK2) |
Target's Patent Info
|
[1] |
|
KEGG Pathway
|
Chemokine signaling pathway
|
|
PI3K-Akt signaling pathway
|
|
Signaling pathways regulating pluripotency of stem cells
|
|
Jak-STAT signaling pathway
|
|
Measles
|
|
HTLV-I infection
|
|
Epstein-Barr virus infection
|
|
Viral carcinogenesis
|
|
Primary immunodeficiency
|
|
Osteoclast differentiation
|
|
Toxoplasmosis
|
|
Hepatitis C
|
|
Influenza A
|
|
Herpes simplex infection
|
|
Leishmaniasis
|
|
Tuberculosis
|
|
Hepatitis B
|
|
Pathways in cancer
|
|
Pancreatic cancer
|
|
NetPath Pathway
|
IL2 Signaling Pathway
|
|
Panther Pathway
|
Interleukin signaling pathway
|
|
JAK/STAT signaling pathway
|
|
PDGF signaling pathway
|
|
Angiogenesis
|
|
Interferon-gamma signaling pathway
|
|
Pathway Interaction Database
|
IL4-mediated signaling events
|
|
CD40/CD40L signaling
|
|
Signaling events mediated by TCPTP
|
|
SHP2 signaling
|
|
IL2-mediated signaling events
|
|
IL2 signaling events mediated by PI3K
|
|
IL2 signaling events mediated by STAT5
|
|
IL27-mediated signaling events
|
|
Signaling events mediated by PTP1B
|
|
IL12-mediated signaling events
|
|
IL6-mediated signaling events
|
|
IL23-mediated signaling events
|
|
p73 transcription factor network
|
|
IFN-gamma pathway
|
|
PDGFR-alpha signaling pathway
|
|
Reactome
|
GPVI-mediated activation cascade
|
|
Interleukin-7 signaling
|
|
G beta:gamma signalling through PI3Kgamma
|
|
Interleukin-2 signaling
|
|
RAF/MAP kinase cascade
|
|
Interleukin receptor SHC signaling
|
|
Interleukin-6 signaling
|
|
MAPK3 (ERK1) activation
|
|
MAPK1 (ERK2) activation
|
|
Interferon alpha/beta signaling
|
|
Regulation of IFNA signaling
|
|
ISG15 antiviral mechanism
|
|
Interferon gamma signaling
|
|
Regulation of IFNG signaling
|
|
WikiPathways
|
IL-2 Signaling Pathway
|
|
IL-4 Signaling Pathway
|
|
Interleukin-2 signaling
|
|
Interleukin-7 signaling
|
|
Oncostatin M Signaling Pathway
|
|
IL-9 Signaling Pathway
|
|
IL-7 Signaling Pathway
|
|
Interleukin-3, 5 and GM-CSF signaling
|
|
Interferon type I signaling pathways
|
|
IL-6 signaling pathway
|
|
Interleukin-11 Signaling Pathway
|
|
Type III interferon signaling
|
|
Interferon alpha/beta signaling
|
|
Type II interferon signaling (IFNG)
|
|
TGF Beta Signaling Pathway
|
|
TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer
|
|
IL-3 Signaling Pathway
|
|
JAK/STAT
|
|
PDGF Pathway
|
|
Prostate Cancer
|
|
TSLP Signaling Pathway
|
|
IL17 signaling pathway
|
|
Leptin signaling pathway
|
|
TSH signaling pathway
|
|
Integrated Breast Cancer Pathway
|
|
Integrated Cancer pathway
|
|
Interferon gamma signaling
|
|
IL-5 Signaling Pathway
|
